HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

RNA expression of human telomerase subunits TR and TERT is differentially affected by melatonin receptor agonists in the MCF-7 tumor cell line.

Abstract
The RNA expression levels of human catalytic subunit (TERT) and the RNA subunit (TR) of telomerase were analysed after treatment with the agonists of the membrane receptor (S 20098) and the nuclear receptor (CGP 52608) for melatonin in the MCF-7 human breast tumor cell line. Neither membrane nor nuclear signalling affected the RNA steady-state levels of the TR subunit of telomerase. On the contrary, we observed a significant decreased in the RNA levels of TERT after treatment with CGP 52608 while S 20098 produced a significant increase in the RNA levels of TERT. These results support a cross-talk between membrane and nuclear melatonin signalling and provide new data on the hormonal regulation of telomerase function.
AuthorsMercedes M Leon-Blanco, Juan M Guerrero, Russel J Reiter, David Pozo
JournalCancer letters (Cancer Lett) Vol. 216 Issue 1 Pg. 73-80 (Dec 08 2004) ISSN: 0304-3835 [Print] Ireland
PMID15500950 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Acetamides
  • Hypnotics and Sedatives
  • Receptors, Melatonin
  • Thiazoles
  • Thiosemicarbazones
  • agomelatine
  • RNA
  • CGP 52608
  • Telomerase
  • Melatonin
Topics
  • Acetamides (pharmacology)
  • Breast Neoplasms (pathology)
  • Catalytic Domain
  • Female
  • Humans
  • Hypnotics and Sedatives (pharmacology)
  • Melatonin (agonists)
  • RNA (biosynthesis)
  • Receptors, Melatonin (physiology)
  • Signal Transduction
  • Telomerase (biosynthesis, genetics)
  • Thiazoles (pharmacology)
  • Thiosemicarbazones (pharmacology)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: